Real-world research with patient experience into focus

Real-world evidence – insights to support better health

Real-world evidence (RWE) provides strategic support across the entire lifecycle of a pharmaceutical product. With deep expertise in real-world data and observational research, we deliver valuable insights and services that support successful progression from clinical development through to post-marketing Phase IV studies.

Comprehensive expertise

Our experienced team offers a wide range of real-world evidence services, including:

• Feasibility studies
• Patient surveys
• Drug utilisation studies
• Phase IV registry studies

Patient-centred data collection

We collect new data on patient-reported outcomes (PROs) in Finland, Sweden, and other countries, offering a unique window into patient perspectives.

Secure digital platform

Our proprietary digital platform for PRO collection ensures secure data handling, fully compliant with the EU General Data Protection Regulation (GDPR).

Holistic insights into disease burden

We generate new perspectives on disease burden by combining PROs with national healthcare registry data to deliver a more complete understanding of patient needs and outcomes.

Market access support

We support market access and pricing strategy with:

• Market research
• Competitive landscape analysis
• Data to inform health economic modelling and reimbursement submissions

The Nordics: a prime environment for registry-based research

The Nordic countries offer excellent conditions for registry-based studies, thanks to harmonised legislation, electronic data availability, and comprehensive nationwide datasets that allow for long-term population-level research.

The formula: RWD + PRO = RWE

Real-world data (RWD):

We collect real-world data from national health registries, hospital data lakes (including electronic health records), private healthcare providers, and biobanks. Studies can also include official data sources such as family relationships, income levels, or criminal records, where relevant and permitted.

Patient-reported outcomes (PRO):

PROs are collected through Oriola’s Research Pharmacy Network, which includes one-fifth of all pharmacies in Finland. In Sweden, we work with leading pharmacy chains. We also partner with patient organisations, and public and private healthcare providers. Our platform supports patient recruitment for clinical trials and market research.

Respondents may include patients, caregivers, pet owners, pharmacists, veterinarians, or healthcare professionals, depending on the study design.

Combining RWD and PRO:

By integrating registry data with patient-reported outcomes, we provide a comprehensive view of disease burden to support better healthcare decision-making

Research pharmacies – experience matters

Real-world effectiveness studies and patient-reported outcome (PRO) data are increasingly used to guide decisions in pharmaceutical care. In research pharmacy operations, pharmacies act as trusted healthcare providers, collecting real-world data to support the development of more effective and personalised treatments.

Real-world effectiveness research in pharmacies

Pharmacies are key partners in gathering insights directly from medicine users about their treatment experiences. Through surveys, we collect current data on quality of life, health behaviours and other relevant aspects of everyday care.

Oriola coordinates an internationally unique research pharmacy network, with one in five pharmacies in Finland already participating. Together with these pharmacies, we carry out several major studies each year across a wide range of therapeutic areas. Participating pharmacies are compensated for their contributions.

Taking part in research strengthens the professional expertise of pharmacy staff. This socially valuable work supports better patient care and makes pharmacists' role in healthcare more visible in daily pharmacy practice.

Research for the benefit of the patient

The goal of real-world effectiveness research is to improve patient outcomes. At the same time, the insights generated benefit the broader healthcare system. Patients are motivated to take part by the opportunity to contribute to the advancement of treatment for their condition. The personalised service provided during research also supports customer engagement and builds loyalty to their trusted research pharmacy.